Vanessa Villaverde

Plaza Construction Corp. engages in the provision of construction and management services to the federal and commercial clients. Its services include construction management, general contracting, program management, design/build and construction consulting. The company was founded in 1986 and is headquartered in New York, NY.

Kathy Ireland Worldwide LLC is a brand that offers designs, products, and services for empowered living. The private company was founded in 1993 by Tommy Meharey and is headquartered in Rancho Mirage, CA with subsidiaries in the United States. The company has an estimated revenue of $2.50 billion from retail in 2015. Kathy Ireland, the company's chair and CEO, is a former supermodel who has been featured on the covers of various magazines, including Forbes, which has recognized her as one of the most successful self-made women. Kathleen Ireland has been the CEO of the company since its inception.

Mammogen, Inc. is a female-led biotechnology company that focuses on improving the detection, diagnosis, and treatment of women's health-related diseases. Mammogen is based in Aliso Viejo, CA and was founded by Martin J. Keiser. The private company's proprietary gentrutm liquid biopsy platform, which leverages novel messenger RNA technology, is used in its flagship gentru-breasttm program to non-invasively detect and diagnose breast cancer. Mammogen's multi-gene expression signature for breast cancer detection has been extensively validated in blood and saliva, and has shown statistical significance towards providing measurable improvement upon current standards of care. The company's product pipeline consists of an array of non-invasive prognostics and diagnostics for additional diseases that affect some-, mostly-, or only-women. Elizabeth Cormier-May has been the CEO of the company since 2021.

Dragonfly Data Factory LLC is an American company that operates an online platform for its clients to mine, manage, and monetize big data. The CEO of the private company is Elizabeth Cormier-May.

Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.

miR Scientific LLC is an American healthcare company that specializes in the early and accurate detection, characterization, and monitoring of urological cancers. The private company has developed a proprietary, non-invasive platform called the miR Disease Management Platform®, which powers the miR Sentinel™ Prostate Cancer Test. This liquid biopsy urine test accurately detects, classifies, and monitors prostate cancer based on the interrogation of sncrnas extracted from non-dre urinary exosomes. The company is developing interoperable products and services to revolutionize the standards of care supporting urologic oncology. miR Scientific is a majority-owned operating subsidiary of Impact NRS LLC, headquartered in the United States with operating subsidiaries in Puerto Rico. The company was founded in 2014 by Rob Tenniswood, Martin Tenniswood, and Sam Salman. Sam Salman has been the CEO since 2014.

Fight Cancer Global, LLC provides a network platform aimed at solving the isolation problems faced by cancer patients. The private company is based in Houston, TX.